鳥居薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/03/05 | 4,465 | 4,540 | 4,430 | 4,500 | +35 | +0.8% | 83,700 |
2025/03/04 | 4,400 | 4,485 | 4,355 | 4,465 | +90 | +2.1% | 164,200 |
2025/03/03 | 4,235 | 4,420 | 4,210 | 4,375 | +200 | +4.8% | 142,300 |
2025/02/28 | 4,250 | 4,300 | 4,170 | 4,175 | -95 | -2.2% | 101,700 |
2025/02/27 | 4,365 | 4,400 | 4,250 | 4,270 | -45 | -1% | 54,500 |
2025/02/26 | 4,245 | 4,360 | 4,245 | 4,315 | +100 | +2.4% | 117,300 |
2025/02/25 | 4,195 | 4,290 | 4,080 | 4,215 | +5 | +0.1% | 101,600 |
2025/02/21 | 4,245 | 4,300 | 4,180 | 4,210 | +35 | +0.8% | 147,100 |
2025/02/20 | 4,215 | 4,220 | 4,160 | 4,175 | -70 | -1.6% | 101,400 |
2025/02/19 | 4,320 | 4,350 | 4,245 | 4,245 | -85 | -2% | 74,300 |
2025/02/18 | 4,200 | 4,340 | 4,160 | 4,330 | +110 | +2.6% | 136,600 |
2025/02/17 | 4,445 | 4,485 | 4,165 | 4,220 | -240 | -5.4% | 260,100 |
2025/02/14 | 4,305 | 4,485 | 4,275 | 4,460 | +180 | +4.2% | 311,800 |
2025/02/13 | 4,200 | 4,300 | 4,190 | 4,280 | +130 | +3.1% | 251,600 |
2025/02/12 | 4,175 | 4,230 | 4,075 | 4,150 | -25 | -0.6% | 323,900 |
2025/02/10 | 4,530 | 4,700 | 4,125 | 4,175 | -855 | -17% | 809,000 |
2025/02/07 | 5,020 | 5,040 | 4,930 | 5,030 | +40 | +0.8% | 174,300 |
2025/02/06 | 4,890 | 5,000 | 4,875 | 4,990 | +115 | +2.4% | 99,100 |
2025/02/05 | 4,850 | 4,880 | 4,825 | 4,875 | -10 | -0.2% | 68,500 |
2025/02/04 | 4,910 | 4,970 | 4,860 | 4,885 | +5 | +0.1% | 116,000 |
2025/02/03 | 4,970 | 4,970 | 4,850 | 4,880 | -100 | -2% | 133,500 |
2025/01/31 | 5,000 | 5,010 | 4,930 | 4,980 | -20 | -0.4% | 74,700 |
2025/01/30 | 5,030 | 5,040 | 4,965 | 5,000 | -10 | -0.2% | 95,200 |
2025/01/29 | 5,030 | 5,050 | 4,990 | 5,010 | -20 | -0.4% | 103,700 |
2025/01/28 | 5,100 | 5,130 | 5,000 | 5,030 | -20 | -0.4% | 90,100 |
2025/01/27 | 5,040 | 5,070 | 5,000 | 5,050 | -20 | -0.4% | 91,600 |
2025/01/24 | 4,940 | 5,110 | 4,930 | 5,070 | +130 | +2.6% | 167,800 |
2025/01/23 | 4,860 | 5,050 | 4,850 | 4,940 | +75 | +1.5% | 261,700 |
2025/01/22 | 4,750 | 4,910 | 4,740 | 4,865 | +185 | +4% | 149,400 |
2025/01/21 | 4,665 | 4,695 | 4,640 | 4,680 | +35 | +0.8% | 64,600 |
2025/01/20 | 4,580 | 4,675 | 4,560 | 4,645 | +65 | +1.4% | 93,700 |
2025/01/17 | 4,590 | 4,590 | 4,520 | 4,580 | ±0 | ±0% | 50,400 |
2025/01/16 | 4,595 | 4,670 | 4,580 | 4,580 | ±0 | ±0% | 78,100 |
2025/01/15 | 4,660 | 4,675 | 4,515 | 4,580 | -95 | -2% | 142,600 |
2025/01/14 | 4,700 | 4,715 | 4,640 | 4,675 | -50 | -1.1% | 86,000 |
2025/01/10 | 4,660 | 4,725 | 4,660 | 4,725 | +10 | +0.2% | 39,800 |
2025/01/09 | 4,650 | 4,725 | 4,650 | 4,715 | +50 | +1.1% | 39,200 |
2025/01/08 | 4,745 | 4,770 | 4,645 | 4,665 | -70 | -1.5% | 83,700 |
2025/01/07 | 4,705 | 4,735 | 4,680 | 4,735 | +75 | +1.6% | 68,900 |
2025/01/06 | 4,705 | 4,705 | 4,640 | 4,660 | -55 | -1.2% | 58,600 |
2024/12/30 | 4,765 | 4,780 | 4,680 | 4,715 | +20 | +0.4% | 81,100 |
2024/12/27 | 4,475 | 4,695 | 4,475 | 4,695 | +260 | +5.9% | 223,800 |
2024/12/26 | 4,450 | 4,505 | 4,425 | 4,435 | +10 | +0.2% | 83,000 |
2024/12/25 | 4,425 | 4,460 | 4,405 | 4,425 | -10 | -0.2% | 35,600 |
2024/12/24 | 4,430 | 4,445 | 4,395 | 4,435 | +30 | +0.7% | 43,800 |
2024/12/23 | 4,430 | 4,440 | 4,400 | 4,405 | +5 | +0.1% | 40,000 |
2024/12/20 | 4,445 | 4,465 | 4,385 | 4,400 | -45 | -1% | 84,400 |
2024/12/19 | 4,405 | 4,495 | 4,390 | 4,445 | +30 | +0.7% | 129,900 |
2024/12/18 | 4,505 | 4,510 | 4,405 | 4,415 | -95 | -2.1% | 93,900 |
2024/12/17 | 4,565 | 4,565 | 4,500 | 4,510 | -30 | -0.7% | 38,900 |
51~
100
件表示中 / 3702件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
サワイGHD | 177,100円 | +5.9% | +24.5% | 3.11% | 11.75倍 | 1.11倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
キッセイ薬 | 388,000円 | +3.6% | +6.1% | 3.09% | 13.07倍 | 0.77倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
科研薬 | 371,900円 | -6.4% | -71.8% | 5.11% | 41.42倍 | 0.92倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 298,700円 | +7.9% | -3.3% | 2.68% | 8.31倍 | 0.85倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム